Summary
Hyper-activation of mitogen-activated protein kinase (MAPK) has recently been reported in several human cancers and activation of MAPK in those cancers may be associated with carcinogenesis through aberrant cell proliferation. To understand the roles of the MAPK pathway in colorectal tumorigenesis, we examined the status of extracellular signal-regulated protein kinases (ERK1/2) in 21 colorectal tumour specimens and compared it with that of paired normals. The specific MAPK activities were two- to tenfold lower in 71% (15 out of 21 cases) of colorectal tumours compared to those in paired normals. The individual MAPK kinase (MEK) correlated with MAPK activities (P = 0.006). Reduction of the MAPK and MEK activities in colorectal tumours was also observed in adenomas. These results suggested that down-regulation of the MAPK cascade may be caused by early genetic event(s) and that it may be related to the loss of normal growth control. Although MAPK activities were down-regulated both in adenomas and carcinomas, activities of the MAPKs in carcinomas were higher than those of paired adenomas. These results suggested that MAPK activities may be increased in the adenoma-to-carcinoma sequence and that it may play a role in the tumour progression. Observation of the differential regulation of MAPK activities in colorectal tumorigeneis suggested roles for the MAPK pathway in both positive and negative controls of cell growth.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Ahnen, DJ, Feiglm, P, Quan, G, Fenoglio-Preiser, C, Lovato, LC, Bunn, Jr PA, Stemmerman, G, Wells, JD, Macdonald, JS & Meyskens, Jr FL (1998). Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. Cancer Res 58: 1149–1158.
Alexander, WS, Adams, JM & Cory, S (1989). Oncogene corporation in lymphocyte transformation: malignant conversion of E mu-myc transgenic pre-B cells in vitro is enhanced by v-H-ras or v-raf but not v-abl. Mol Cell Biol 9: 67–73.
Attar, BM, Atten, MJ & Holian, O (1996). MAPK activity is down-regulated in human colon adenocarcinoma: correlation with PKC activity. Anticancer Res 16: 395–400.
Atten, MJ, Attar, BM & Holian, O (1995). Decreased MAP kinase activity in human gastric adenocarcinoma. Biochem Biophys Res Commun 212: 1001–1006.
Blenis, J (1993). Signal transduction via the MAP kinases: proceed at your own RSK. Proc Natl Acad Sci USA 90: 5889–5892.
Bos, JL (1989). Ras oncogenes in human cancer. Cancer Res 49: 4682–4689.
Cobb, MH & Goldsmith, EJ (1995). How MAP kinases are regulated. J Biol Chem 270: 14843–14846.
Dent, P, Jelinek, T, Morrison, DK, Weber, MJ & Sturgill, TW (1995). Reversal of Raf-1 activation by purified and membrane-associated protein phosphatase. Science 268: 1902–1905.
Fearon, ER & Vogelstein, BA (1990). Genetic model for colorectal tumorigenesis. Cell 61: 759–767.
Groom, LA, Sneddon, AA, Alessi, DR, Dowd, S & Keyse, SM (1996). Differential regulation of the MAP, SAP and RK/p38 kinases by Pyst1, a novel cytosolic dual-specificity phosphatase. EMBO J 15: 3621–3632.
Guillem, JG, O’Brian, CA, Fitzer, CJ, Frode, KA, LoGerfo, P, Treat, M & Weinstein, IB (1987). Altered levels of protein kinase C and Ca2+-dependent protein kinases in human colon carcinomas. Cancer Res 47: 2036–2039.
He, T-C, Sparks, BAB, Rago, C, Hermeking, H, Zawel, L, da Costa, LT, Morin, PJ, Vogelstein, B & Kinzler, KW (1998). Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512.
Janes, PW, Daly, RJ, deFazio, A & Sutherland, RL (1994). Activation of the Ras signaling pathway in human breast cancer cells overexpressing erbB-2. Oncogene 9: 3601–3608.
Kinzler, KW & Vogelstein, B (1996). Lessons from hereditary colorectal cancer. Cell 87: 159–170.
Kopp, R, Noelke, B, Sauter, G, Schildberg, FW, Paumgartner, G & Pfeiffer, A (1991). Altered protein kinase C activity in biopsies of human colonic adenomas and carcinomas. Cancer Res 51: 205–210.
Lange-Carter, CA, Pleiman, CM, Gardner, AM, Blumer, KJ & Johnson, GL (1993). A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260: 315–319.
Magnuson, NS, Beck, T, Vahidi, H, Hahn, H, Smola, U & Rapp, UR (1994). The Raf-1 serine/threonine protein kinase. Semin Cancer Biol 5: 247–253.
Marais, R, Wynne, J & Treisman, R (1993). The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73: 381–393.
Marais, R, Light, Y, Mason, C, Paterson, H, Olson, MF & Marshall, CJ (1998). Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280: 109–111.
Marcus, KB, Bossoue, SA & Patel, AJ (1992). Myc function and regulation. Ann Rev Biochem 61: 809–860.
Marshall, CJ (1995). Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185.
Oka, H, Chatani, Y, Hoshino, R, Ogawa, O, Kakehi, Y, Terachi, T, Okada, Y, Kawaichi, M, Kohno, M & Yoshida, O (1995). Constitutive activation of mitogen-activated protein (MAP) kinase in human renal cell carcinoma. Cancer Res 55: 4182–4187.
Owen, AJ, Pantazis, P & Antoniades, HN (1984). Simian sarcoma virus-transformed cells secrete a mitogen identical to platelet derived growth factor. Science 225: 54–56.
Pumiglia, KM & Decker, JD (1997). Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. Proc Natl Acad Sci USA 94: 448–452.
Sewing, A, Wiseman, B, Lloyd, AC & Land, H (1997). High-intensity Raf signaling cause cell cycle arrest mediated by p21Cip. Mol Cell Biol 17: 5588–5597.
Simon, B, Weinel, R, Hohne, M, Watz, J, Schmidt, J, Kortner, G & Arnold, R (1994). Frequent alterations of the tumor suppressor genes p53 and DCC in human pancreatic carcinoma. Gastroenterology 106: 1645–1651.
Sivaraman, VS, Wang, H-Y, Nuovo, GJ & Malbin, CC (1997). Hyperexpression of mitogen-activated protein kinase in human breast cancer. J Clin Invest 99: 1478–1483.
Slamon, DJ, Godolphin, W, Jones, LA, Wong, SG, Keith, DE, Levin, WJ, Stuart, SG, Udove, J, Ullrich, A & Press, MF (1989). Studies of the HER-2 neu proto-oncogene in human breast and ovarian cancer. Science 244: 707–712.
Spandidos, DA & Kerr, IB (1984). Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. Br J Cancer 49: 681–688.
Stevenson, MA, Pollock, SS, Coleman, CN & Calderwood, SK (1994). X-irradiation, phorbolester, and H2O2 stimulate mitogen-activated protein kinase activity in HIH-3T3 cells through the formation of reactive oxygen intermediates. Cancer Res 54: 12–15.
Towatari, M, Iida, H, Tanimoto, M, Iwata, H, Hamaguchi, M & Saito, H (1997). Constitutive activation of mitogen-activated protein kinase pathway in acute leukemia cells. Leukemia 11: 479–484.
Vogel, US, Dixon, RAF, Schaber, MD, Diel, RE, Marshall, EM, Scolnick, EM, Sigal, IS & Gibbs, JB (1988). Cloning of bovine GAP and its interaction with oncogenic Ras. Nature 335: 90–93.
Vogelstein, B, Fearon, ER, Hamilton, SR, Kern, SE, Preisninger, AC, Leppert, M, Nakamura, Y, White, R, Smits, AMM & Bos, JL (1988). Genetic alterations during colorectal tumor development. N Engl J Med 319: 525–532.
Woods, D, Parry, D, Cherwinski, H, Bosch, E, Lees, E & McMahon, M (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17: 5598–5621.
Yao, B, Zhang, Y, Dellkat, S, Mathias, S, Basu, S & Kolesnick, R (1995). Phosphorylation of Raf by ceramide-activated protein kinase. Nature 378: 307–310.
Zheng, CF & Kuan, KL (1993). Cloning and characterization of two distinct human extracellular signal-regulated kinase activator kinases, MEK1 and MEK2. J Biol Chem 268: 11435–11439.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Park, KS., Kim, NG., Kim, J. et al. Differential regulation of MAP kinase cascade in human colorectal tumorigenesis. Br J Cancer 81, 1116–1121 (1999). https://doi.org/10.1038/sj.bjc.6690817
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690817
Keywords
This article is cited by
-
Research progress of ursolic acid’s anti-tumor actions
Chinese Journal of Integrative Medicine (2014)
-
Expression of EGFR, HER2, Phosphorylated ERK and Phosphorylated MEK in Colonic Neoplasms of Familial Adenomatous Polyposis Patients
Journal of Gastrointestinal Cancer (2012)
-
Roles of Hormones and Signaling Molecules in Describing the Relationship Between Obesity and Colon cancer
Pathology & Oncology Research (2011)
-
Extracellular zinc stimulates ERK‐dependent activation of p21Cip/WAF1 and inhibits proliferation of colorectal cancer cells
British Journal of Pharmacology (2002)
